Related Experiment Video
Updated: Jun 14, 2025
12:03
Receptor Autoradiography Protocol for the Localized Visualization of Angiotensin II Receptors
Published on: June 7, 2016
17.8K
Gating Mechanism for Biased Agonism at Angiotensin II Type 1 Receptors
Graham J Moore1, Harry Ridgway2,3, Laura Kate Gadanec4
1Pepmetics Inc., 772 Murphy Place, Victoria, BC V6Y 3H4, Canada.
Molecules (Basel, Switzerland)
|June 13, 2025
Summary
Angiotensin II (AngII) interactions with AT1 receptors involve proton hopping pathways. These pathways, involving a charge relay system (CRS), dictate distinct physiological outcomes like vasoconstriction or vasodilation.
Area of Science:
- Biochemistry
- Molecular Pharmacology
- Computational Chemistry
Background:
- Angiotensin II (AngII) is a key regulator of blood pressure.
- AngII type 1 receptors (AT1R) mediate AngII's physiological effects.
- Understanding AngII-AT1R interaction mechanisms is crucial for cardiovascular drug development.
Purpose of the Study:
- To elucidate the proton hopping pathways in AngII-AT1R interactions.
- To investigate the role of the charge relay system (CRS) in receptor signaling.
- To correlate specific CRS pathways with distinct physiological outcomes.
Main Methods:
- Analysis of structure-activity data for AngII analogs.
- Quantum mechanical (semiempirical) calculations of proton transfer.
- Investigating receptor binding and signaling mechanisms.
Main Results:
- Two distinct proton hopping pathways identified within the AngII-AT1R complex.
- The charge relay system (CRS) involving Tyr4, His6, and receptor residues (D281, K199) acts as a gating mechanism.
- Pathway 1 (Tyr4-His6) promotes G protein signaling, vasoconstriction.
- Pathway 2 (Tyr4-Phe8) promotes arrestin signaling, vasodilation, and desensitization.
Conclusions:
- The identified proton hopping pathways provide a mechanistic basis for AT1R signaling diversity.
- Findings offer insights for designing targeted angiotensin receptor blockers (sartans) and novel bisartans.
- This study enhances the understanding of molecular mechanisms underlying cardiovascular regulation.
More Related Videos
Related Concept Videos
01:30Antihypertensive Drugs: Angiotensin II Receptor Blockers
606
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
606
01:31Adrenergic Receptors: ɑ Subtype
1.5K
Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
1.5K
01:30Ligand-Gated Ion Channel Receptor: Gating Mechanism
2.2K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
2.2K
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
500
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
500
01:21G-Protein Gated Ion Channels
4.5K
GPCRs are primarily responsible for our sense of smell, taste, and vision. The binding of a sensory stimulus activates GPCR to stimulate effector proteins, many of which are ion channels in the sensory organs. GPCRs modulate the opening and closing of the target ion channels either directly by binding them, or by releasing second messengers that activate these channels. As ions move across the membrane, the membrane potential is altered, which induces an appropriate response.
Sensory...
Sensory...
4.5K
01:25Antihypertensive Drugs: Direct Renin Inhibitors
510
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
510